Chang Yan Y - OmicsDI

Show results for

Unknown (846)
Proteomics (53)
Transcriptomics (7)
Multiomics (6)
Metabolomics (4)
Genomics (2)

Organisms

Homo sapiens (29)
Andropogon gerardi (16)
Bacteria (16)
Canis lupus familiaris (16)
Cnidaria (16)
Cricetulus griseus (16)
Eukaryota (16)
Fasciola (16)
Hepatitis B virus (16)
Human betaherpesvirus 5 (16)
Madurella mycetomatis (16)
Mesocricetus auratus (16)
Miscanthus x giganteus (16)
Mus musculus (16)
Mycobacterium tuberculosis (16)
Orthoflavivirus (16)
Panicum virgatum (16)
Platyhelminthes (16)
Pseudomonas aeruginosa AES-1R (16)
Rattus norvegicus (16)
Rattus rattus (16)
Rhodococcus jostii RHA1 (16)
Saccharomyces cerevisiae (16)
Mus musculus (8)
Arabidopsis thaliana (2)
Saccharomyces cerevisiae (2)
Bombus terrestris (1)
Elaeagnus angustifolia (1)
Gallus gallus (1)
Glaesserella parasuis (1)

Repository

iProX (31)
pride (16)
biostudies-arrayexpress (7)
MetaboLights (4)
MassIVE (3)
PeptideAtlas (3)
EGA (2)

Tissue

Liver (5)
Permanent cell line cell (4)
Others (3)
Colon (3)
Cell culture (2)
Heart (2)
Spleen (2)
Testis (2)
Blood plasma (1)
Bone marrow (1)
Brain (1)
Cell suspension culture (1)
Cerebrospinal fluid (1)
Cotyledon (1)
Dendritic cell (1)
Embryo (1)
Endosperm (1)
Erythrocyte (1)
Esophageal squamous epithelium (1)
Kidney (1)
Leaf (1)
Lung (1)
Lymph node (1)
Placenta (1)
Primary cell (1)
Prostate gland (1)
Rosette (1)
Saliva (1)
Small intestine (1)
Urine (1)

Disease

Cardiovascular system disease (1)
Diabetic retinopathy (1)
Esophageal cancer (1)
Lymphoma (1)

Technology Type

Mass Spectrometry (16)
Shotgun proteomics (8)
Bottom-up proteomics (5)
Mass spectrometry (4)
Affinity purification coupled with mass spectrometry proteomics (3)

Instrument Platform

MS:1000031 (3)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (2)
LTQ Orbitrap Elite (2)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
QExactive (1)

Publication Date

2024 (9)
2023 (9)
2022 (9)
2014 (5)
2025 (5)
2013 (4)
2020 (4)
2019 (4)
2012 (3)
2021 (3)
2016 (3)
2018 (2)
2017 (2)
2011 (1)
2026 (1)

UNIPROT ID/AC

A0A024R563 (3)
A0A024R8H9 (3)
A0A024RAN2 (3)
A0A024RC46 (3)
A0A087WUD1 (3)
A0A087WVZ5 (3)
A0A087WWK8 (3)
A0A087WXI0 (3)
A0A087WZE9 (3)
A0A087X1S3 (3)
A0A0A0MR66 (3)
A0A0A0MS51 (3)
A0A0A0MSA7 (3)
A0A0B4J220 (3)
A0A0C4DG89 (3)
A0A0C4DGT3 (3)
A0AV96 (3)
A0AVT1 (3)
A0FGR8 (3)
A0FGR8-2 (3)
A0FGR8-6 (3)
A0JLT2 (3)
A0JNW5 (3)
A0MZ66 (3)
A0PJW6 (3)
A0PK00 (3)
A1A4S6 (3)
A1L0T0 (3)
A1L170 (3)
A1L390 (3)

ENSEMBL ID

ENSG00000147251 (3)
ENSG00000170477 (3)
ENSG00000247315 (3)

CHEBI ID

CHEBI:16040 (3)
CHEBI:30832 (3)
CHEBI:17154 (3)
CHEBI:42534 (3)
CHEBI:16335 (3)
CHEBI:17568 (3)
CHEBI:7916 (3)
CHEBI:16704 (3)
CHEBI:15354 (3)
CHEBI:18344 (3)
CHEBI:16990 (3)
CHEBI:16796 (2)
CHEBI:84849 (2)
CHEBI:89649 (2)
CHEBI:17890 (2)
CHEBI:2295 (2)
CHEBI:125610 (2)
CHEBI:15367 (2)
CHEBI:24266 (2)
CHEBI:17869 (2)
CHEBI:138367 (2)
CHEBI:17521 (2)
CHEBI:18308 (2)
CHEBI:16974 (2)
CHEBI:30805 (2)
CHEBI:33508 (2)
CHEBI:16450 (2)
CHEBI:36751 (2)
CHEBI:28483 (2)
CHEBI:16755 (2)

Metabolite Name

Kynurenic acid (3)
12-aminododecanoic acid (2)
Pyrrole-2-carboxylic acid (2)
Uracil (2)
Methyl jasmonate (2)
Cortisone (2)
Indole (2)
Adenosine (2)
Spermidine (2)
Creatinine (2)
Hypoxanthine (2)
3-acetyl-11-keto-beta-boswellic acid (1)
1-linoleoyl glycerol (1)
3-methyl-2-oxindole (1)
2-trans-hexadecenoic acid (1)
Rac-glycerol 1-myristate (1)
Methyl 2-hydroxy-4-{3-[(4-oxo-3-phenyl-4h-chromen-7-yl)oxy]propoxy}-3-propylbenzoate (1)
Palmitelaidic acid methyl ester (1)
5-hydroxy-3-(hydroxymethyl)-6-isopropyl-2-oxo-3-cyclohexen-1-yl 3-methylpentanoate (1)
19-nortestosterone (1)
N-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbothioamide (1)
7-hydroxytestosterone (1)
4-(methylthio) aniline (1)
Methyl 4-(aminocarbonyl)-n-cyanotetrahydropyridine-1(2H)-carbimidothioate (1)
Senkyunolide h (1)
Alpha-pinene-2-oxide (1)
18-beta-glycyrrhetinic acid (1)
Ethyl 3-[2-(diphenylmethylidene)hydrazino]but-2-enoate (1)
N-[3-(aminosulfonyl)phenyl]-2-phenoxynicotinamide (1)
(+/-)-c75 (1)

Study type

Transcription profiling by array (3)
RNA-seq of coding RNA (2)
ChIP-chip by tiling array (1)
Comparative genomic hybridization by array (1)

Release Date

2025 (143)
2022 (136)
2023 (102)
2024 (101)
2021 (101)
2020 (51)
2019 (47)
2018 (46)
2017 (27)
2016 (22)
2015 (19)
2012 (14)
2026 (12)
2013 (11)
2014 (7)
2011 (7)
2009 (2)
2008 (2)
2010 (1)
1997 (1)
1996 (1)

Lab affiliation

Beijing proteome research center (3)
Changhai Hospital, Naval Medical University, Shanghai, 200433, China. (1)
Department of Gastroenterology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China (1)
Department of Pediatrics Medizinische Fakultät Carl Gustav Carus Technische Universität Dresden 01307 Dresden, Germany (1)
Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, (1)
National Center of Biomedical Analysis (1)
Sichuan Academy of Grassland Sciences (1)
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China. (1)
The Institute of Cancer Research (1)
Translational Biomedical Proteomics, Institute of Molecular and Cell Biology (IMCB), Singapore (1)
Tsinghua University (1)
Univeristy of California, San Francisco (1)
Xi'an International Medical Center Hospital (1)
Zhengzhou University (1)

Previous page
1 / 92
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 92
Next page

Sort by:

Relevance

Page size

The pharmacological evidence of the chang-yan-ning formula in the treatment of colitis.

Not available

S-EPMC9579319 | biostudies-literature

Metabolome and transcriptome integration reveals insights into petals coloration mechanism of three species in Sect. Chrysantha chang.

Not available

S-EPMC11034495 | biostudies-literature

Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.

Not available

S-EPMC8543852 | biostudies-literature

Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer.

Not available

S-EPMC8642943 | biostudies-literature

Hepatitis G virus infection in patients with chronic non-A-E hepatitis.

Not available

S-EPMC4842868 | biostudies-literature

Predicting the DPP-IV inhibitory activity pIC₅₀ based on their physicochemical properties.

Not available

S-EPMC3705804 | biostudies-literature

Biomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis.

Not available

S-EPMC8895626 | biostudies-literature

Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression

Not available

S-EPMC9461185 | biostudies-literature

MS for identifying CENP-E ubiquitination sites and MS for GST-Ub4 interacting proteins

LUBAC mediates the linear ubiquitination of CENP-E and facilitates the anchoring of CENP-E by KNL1 at attached kinetochores

ORGANISM(S): Homo sapiens (Human)

2019-01-28 | PXD011786 | Pride

Cenp-e Knl1

Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains

Cyanobacterial harmful algal blooms (cHABs) dominated by Microcystis aeruginosa threaten the ecological integrity and beneficial uses of lakes globally. In addition to producing hepatotoxic microcystins (MC), M. aeruginosa exudates (MaE) contain various compounds with demonstrat...

2023-01-16 | MTBLS6603 | MetaboLights

Previous page
1 / 92
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 92
Next page

Sort by:

Relevance

Page size

912 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets